Company Profile
Ablatus Therapeutics Limited
09812865•Private Limited With Share Capital
Get Full Access
07/10/2015
10 years
5
3
72190
not scored
Company Overview
Registration, classification & business activity
Ablatus Therapeutics Limited (09812865) is a private limited with share capital incorporated on 07/10/2015 (10 years old) and registered in leeds, LS115HL. The company operates under SIC code 72190 - other research and experimental development on natural sciences and engineering.
Ablatus therapeutics is the first spin-out company from the norfolk and norwich university hospital and is developing bimodal electric tissue ablation (beta) - a revolutionary innovative ablation technology for the treatment of solid tumours. traditional radiofrequency ablation (rfa) uses alternatin...
Financial Overview
£1.33M
£21.3K
£1.31M
£125.3K
Key Metrics
3
Employees
5
Directors
38
Shareholders
1
Patents
Board of Directors
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Innovate Grants
This company received a grant of £268818.0 for Bimodal Electric Tissue Ablation - Next Generation Radiofrequency Ablation. The project started on 01/09/2017 and ended on 31/05/2019.
This company received a grant of £672972.0 for Bimodal Electric Tissue Ablation: First-In-Person Clinical Study. The project started on 01/08/2020 and ended on 31/07/2022.
Risk Assessment
not scored
International Score